Status:
COMPLETED
Pioglitazone Treatment in Polycystic Ovary Syndrome
Lead Sponsor:
Odense University Hospital
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
In this study, the investigators wish to investigate how pioglitazone treatment effects hirsute women. Hirsute women are often overweight and have an increased amount of male sex hormone in their bloo...
Eligibility Criteria
Inclusion
- Irregular menses, i.e. cyclus length of \>36 days
- Premenopausal
- Increased fasting insulin \> 50 pmol/l
- Increased free testosterone \> 0.035 nmol/l
Exclusion
- Age: \<18 years
- Contraceptive pill within the past 3 months
- Postmenopausal (increased FSH)
- Known diabetes mellitus, endocrine disease or other disease requiring treatment
- Drug use
- Pregnancy
- Planned pregnancy during the treatment period
- Increased liver parameters
Key Trial Info
Start Date :
September 1 2002
Trial Type :
INTERVENTIONAL
End Date :
January 1 2007
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00145340
Start Date
September 1 2002
End Date
January 1 2007
Last Update
September 26 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Endocrinology, Odense University Hospital
Odense, Funen, Denmark, 5000